Bryanj Watts News Today

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.56 and last traded at $14.79, with a volume of 172121 shares changing hands. The stock had previously closed at $15.56. Analyst Ratings Changes DNLI has been the […]

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.56 and last traded at $14.79, with a volume of 172121 shares trading hands. The stock had previously closed at $15.56. Analysts Set New Price Targets Several analysts have issued […]

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.56 and last traded at $14.79, with a volume of 172121 shares changing hands. The stock had previously closed at $15.56. Analyst Ratings Changes DNLI has been the […]

Denali Therapeutics (NASDAQ:DNLI – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.05), Briefing.com reports. Denali Therapeutics had a negative return on equity of 11.54% and a negative net margin of 36.51%. During the same […]

Bryan Watts, 39, had traveled to Palm Coast to help his brother settle the estate of the two men's late father, who lived on Village Circle. The pair ended up arguing, with Watts arming himself with a semi-automatic handgun.

University of Texas Texas AM Investment Managment Co. acquired a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 36,513 shares of the company’s stock, valued at approximately $1,077,000. Denali Therapeutics comprises 0.4% of University […]

B. Riley started coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Get Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $38.00 price target on the stock. B. Riley’s price target would suggest a potential upside of 57.15% from the stock’s current […]

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $23.84, but opened at $24.57. Denali Therapeutics shares last traded at $24.03, with a volume of 48,555 shares changing hands. Analyst Upgrades and Downgrades Several brokerages recently issued reports on […]

Profund Advisors LLC increased its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 228.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 48,827 shares of the company’s stock after acquiring an additional 33,960 shares during the quarter. Profund Advisors LLC’s holdings in […]

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) CEO Ryan J. Watts sold 2,309 shares of the firm’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $22.59, for a total value of $52,160.31. Following the completion of the transaction, the chief executive officer now owns 2,242,604 […]